Author:
Kumar Ravindra,Mishra Sweta,Gwal Anil,Shanmugam Rajasubramaniam
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010.
2. Shrikhande AV, Arjunan A, Agarwal A, Dani A, Tijare J, Gettig E, et al. Prevalence of the β(S) gene among scheduled castes, scheduled tribes and other backward class groups in Central India. Hemoglobin. 2014;38(4):230–5.
3. Colah RB, Mukherjee MB, Martin S, Ghosh K. Sickle cell disease in tribal populations in India. Indian J Med Res. 2015;141(5):509–15.
4. Sinha S, Seth T, Colah RB, Bittles AH. Haemoglobinopathies in India: estimates of blood requirements and treatment costs for the decade 2017–2026. J Community Genet. 2020;11(1):39–45.
5. National Health Mission. Ministry of Health and Family Welfare. Government of India. Guidelines on prevention and control of Hemoglobinopathies in India. Available at http://www.nhm.gov.in/images/pdf/infocus/NHM_Guidelines_on_Hemoglobinopathies_in_India.pdf. Assessed on 5 November 2019.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献